DFTX
Definium Therapeutics, Inc. has filed 445 public company documents between 2020 and 2026. The most frequent type is insider trade (126 filings), alongside the regular cadence of annual reports, quarterly reports, and event disclosures every public company must make. Use the filters to focus on one filing type, or flip the sort to trace the company's history from its earliest paperwork.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Type | Filing | Filed | Period covered | Open |
|---|---|---|---|---|
| 3 | New insider ownership | 3y ago2023-04-14 | 2023-04-13 | View filing |
| 8-K | Major company event | 3y ago2023-04-14 | 2023-04-14 | View filing |
| 4 | Insider trade | 3y ago2023-03-17 | 2023-03-14 | View filing |
| 4 | Insider trade | 3y ago2023-03-17 | 2023-03-14 | View filing |
| 4 | Insider trade | 3y ago2023-03-17 | 2023-03-14 | View filing |
| 4 | Insider trade | 3y ago2023-03-17 | 2023-03-14 | View filing |
| 4 | Insider trade | 3y ago2023-03-17 | 2023-03-14 | View filing |
| S-8 | Employee stock plan | 3y ago2023-03-14 | - | View filing |
| 8-K | Major company event | 3y ago2023-03-13 | 2023-03-13 | View filing |
| 10-K | Annual report | 3y ago2023-03-09 | 2022-12-31 | View filing |
| 8-K | Major company event | 3y ago2023-03-09 | 2023-03-09 | View filing |
| 4 | Insider trade | 3y ago2023-03-02 | 2023-03-01 | View filing |
| 4 | Insider trade | 3y ago2023-03-02 | 2023-03-01 | View filing |
| SC 13G/A | Passive ownership stake (update) | 3y ago2023-02-14 | - | View filing |
| 8-K | Major company event | 3y ago2023-01-09 | 2023-01-09 | View filing |